By Faith Patenaude, Investor Research Analyst, LSN
The upcoming Redefining Early Stage Investments (RESI) Conference in London is shaping up to be a remarkable event for life science innovators worldwide. The conference will be taking place in-person on December 4 at 11 Cavendish Square, followed by virtual partnering on December 5-6. RESI London 2024 is set to connect ambitious life science start-ups with a diverse array of early-stage investors and strategic partners from across the globe.
Featured RESI London Investors
RESI’s reach goes well beyond the UK. While London-based investors like Delin Ventures, Boost Capital Partners, and Calculus Capital will be actively participating, RESI London 2024 will also welcome an extensive lineup of international firms, opening doors to far-reaching networks and growth opportunities.
European representation will be especially strong. In addition to local players, leading firms such as M Ventures from The Netherlands and CVX Ventures from Denmark will be present, providing crucial European connections for attending start-ups.
But the participation doesn’t stop at Europe. From the United States, esteemed investors like Optum Ventures and Lifespan Vision Ventures will take part in the event. Expanding beyond the Eastern Hemisphere, attendees can connect with firms such as Teijin Pharma from Japan, and Brandon Capital Partners from Australia, all of whom are eager to explore new partnerships with innovative life science start-ups.
RESI London 2024 offers an unparalleled chance to engage with a diverse and globally-minded group of investors. Interested in joining? Contact us at resi@lifesciencenation.com or click here to learn more.
Next Phase Newsletter 
Leave a comment